September 22, 2026
Business Wire

STAT+ | What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators

Documents posted ahead of a key advisory committee meeting may offer clues about what happens next with the test, called Galleri.

By Matthew Herper


STAT+ | Radiopharma companies merge after one receives surprise FDA rejection

ITM Isotope Technologies said Sunday that it will acquire Telix Pharmaceuticals in deal worth at least $1.65 billion.

By Allison DeAngelis


Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?

Research shows that specific integrative therapties reduce cancer-related pain, fatigue, anxiety, and nausea. Why won't insurance pay?

By Lorenzo Cohen



More around STAT

In other news

  • In Sudan, attacks on hospitals force patients to make dangerous journeys, STAT
  • Bayer sells cancer drug to Gruenenthal for up to $431 milllion, Wall Street Journal
  • Insurance coverage lags as cancer science, treatment move forward, KFF Health News

 
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.